Stockreport

Why Intellia Therapeutics, Inc. Stock Lost 19.2% in March [The Motley Fool]

Intellia Therapeutics, Inc.  (NTLA) 
Last intellia therapeutics, inc. earnings: 2/27 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.intelliatx.com/investor-overview
PDF The gene-editing company's stock hit a lifetime high last month but sold off on weaker-than-expected earnings results. Keith Noonan [Read more]